Outlook Therapeutics appoints Kevin Lundquist as CFO
Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it prepares for a U.S. commercial launch of LYTENAVA.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.